SMAD4 and ovarian carcinoma: Furthermore, miR-183 is highly expressed in ovarian cancer cells (Li, et al., 2012; Chen, et al., 2016; Qi, et al., 2019), and the down-regulation of miR-183 can inhibit cell proliferation and induce apoptosis of SMAD family member 4 (Zhou, et al., 2019).